Dev48
Language
  • About
  • Services
  • Industries
  • Technologies
  • Articles
  • Contacts
Book a call
    Home/Articles/Amgen ranks 4 on forbes most innovative large companies list
Dev48
info@dev48.org+375 29 320-40-96WhatsApp@isky_by

© 2026 · All rights reserved.

Amgen Ranks #4 on Forbes’ Most Innovative Large Companies List

Фото: birder62 (Pixabay) — https://pixabay.com/photos/giraffes-heads-ossicones-901009/

Source: Amgen•September 25, 2026 at 06:10 AM

Amgen Ranks #4 on Forbes’ Most Innovative Large Companies List

Amgen has been ranked #4 on Forbes’ inaugural list of America’s Most Innovative Large Companies, recognizing the company among the nation’s leaders in innovation.

Amgen has been ranked #4 on Forbes' inaugural list of America's Most Innovative Large Companies, recognizing the company among the nation's leaders in innovation.

To develop the ranking, Forbes analyzed all companies in the S&P 500 and selected the 100 highest-scoring companies. The methodology considered R&D spending relative to sales, patents and other intellectual property activity, investor confidence, return on equity, media and social sentiment related to innovation, and assessments of companies' innovation activity.

Amgen ranked #4 overall, behind Eli Lilly, Apple, and Nvidia.

Amgen's ranking reflects the company's longstanding focus on innovation and its approach to harnessing the best of biology and technology to discover, develop, manufacture, and deliver innovative medicines for patients.

For more than 45 years, Amgen has helped advance biotechnology by applying new scientific insights and technologies to some of the world's toughest diseases. Today, that work continues across the company—from the use of human genetics and artificial intelligence in drug discovery to advances in medicine development and manufacturing.

Learn more about Forbes' America's Most Innovative Large Companies list and methodology.

FAQ

Amgen ranked #4 overall, behind Eli Lilly, Apple, and Nvidia.

For investors, Amgen's recognition as one of America's Most Innovative Large Companies highlights the company's continued investment in scientific research, artificial intelligence in drug discovery, and advanced manufacturing. These capabilities support Amgen's efforts to advance its pipeline, develop and manufacture innovative medicines, and drive long-term growth.

Companies are evaluated using Forbes' Innovation Index, which measures innovation across a range of factors, including research and development, intellectual property activity, investor confidence, financial performance, and perceptions of innovation.

In addition to the Forbes' innovation recognition, Amgen has been named to lists like Forbes' America's Best Large Employers, TIME's World's Most Impactful Companies, and The Wall Street Journal's Best Companies for the Future.

← All articles

What this article says

More in HealthTech & MedTech

All →
What to Do if You’re Going Through Diabetes Burnout
Dexcom

What to Do if You’re Going Through Diabetes Burnout

New Dexcom G7 15 Day CGM: Easy to use, Longer Wear Time, More Accurate
Dexcom

New Dexcom G7 15 Day CGM: Easy to use, Longer Wear Time, More Accurate

Time in Range for Diabetes Management with CGM
Dexcom

Time in Range for Diabetes Management with CGM

Levine Heart and Wellness Delivers Proactive Care
Athenahealth

Levine Heart and Wellness Delivers Proactive Care

Bourne Family Medicine Maximizes Revenue
Athenahealth

Bourne Family Medicine Maximizes Revenue

Orthopedic Sports Clinic Improves Patient Volumes
Athenahealth

Orthopedic Sports Clinic Improves Patient Volumes

More from Amgen

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancerПресса
Amgen

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS
Amgen

TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS

AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026
Amgen

AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026

When Colorectal Cancer Strikes Early
Amgen

When Colorectal Cancer Strikes Early

Shane Lowry Secures Record Home Victory at the 2026 Amgen Irish Open
Amgen

Shane Lowry Secures Record Home Victory at the 2026 Amgen Irish Open

When Colorectal Cancer Strikes Early
Amgen

When Colorectal Cancer Strikes Early